Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 965d5a7fdca4cf05-LAX IP: 47.97.18.252 UTC time: 2025-07-27T16:01:06+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4